A nearly 200-year-old Massachusetts statute outlining the penalties for corporate manslaughter is being thrust into the spotlight again as lawmakers on Beacon Hill and in Congress wrestle with the fallout from a deadly meningitis outbreak linked to a local compounding pharmacy.
A 71-year-old Andover woman may be Massachusetts’ first case of fungal meningitis linked the embattled Framingham pharmacy company at the center of a deadly nationwide outbreak, WBZ-TV has learned.
Matthew Spencer, the Mayor of Somersworth, New Hampshire is looking better, but disappointed with the NECC, the FDA and Massachusetts.
The bi-partisan instinct is always to fudge, evade, and deflect, out of vanity, perhaps, or political defensiveness.
The owner and director of the specialty pharmacy tied to a deadly meningitis outbreak declined to testify Wednesday morning before a congressional committee investigating the matter.
Massachusetts Health and Human Services Secretary JudyAnn Bigby says state overseers and the managers of a compounding pharmacy bear responsibility for a fatal, nationwide outbreak of fungal meningitis.
The head of the Massachusetts health department says investigators still don’t know why regulators backed off a severe penalty against the New England Compounding Center in 2004.
Nearly a decade ago, federal health inspectors wanted to shut down the Framingham pharmacy linked to a recent deadly meningitis outbreak until it cleaned up its operations, according to congressional investigators.
Federal health inspectors found more than a dozen manufacturing problems, including leaky ceilings and insects, at Ameridose.
The state’s oversight of compounding pharmacies will be the subject of a legislative hearing.